JESSE SERGENT: Open Payments
NPI 1215573647 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 34 payments from 12 companies in 2025. Trend: 2023 $566 · 2024 $1,167 · 2025 $657
Food & beverage: $657Education: $0
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $139 |
| Otsuka America Pharmaceutical, Inc. | 6 | $127 |
| Lilly USA, LLC | 5 | $106 |
| Travere Therapeutics, Inc. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Calliditas Therapeutics US Inc. | 2 | $41 |
| Vifor Pharma, Inc. | 1 | $34 |
| AKEBIA THERAPEUTICS INC | 1 | $25 |
| Novo Nordisk Inc | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: Kerendia, JARDIANCE, JYNARQUE, TARPEYO, Veltassa, FARXIGA, VOYXACT, Vafseo.
Industry payments across KY — which companies pay providers there.
